Deciphering mechanisms controlling placental artery endothelial cell migration stimulated by vascular endothelial growth factor

Endocrinology. 2010 Jul;151(7):3432-44. doi: 10.1210/en.2009-1305. Epub 2010 May 12.

Abstract

Vascular endothelial growth factor (VEGF) stimulated fetoplacental artery endothelial (oFPAE) cell migration and activated multiple signaling pathways including ERK2/1, p38MAPK, Jun N-terminal kinase (JNK1/2), v-Akt murine thymoma viral oncogene homolog 1 (Akt1), and c-Src in oFPAE cells. VEGF-induced cell migration was blocked by specific kinase inhibitors of JNK1/2 (SP600125), c-Src (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d] pyrimidine), and phosphatidylinositol 3-kinase/Akt (wortmannin) but not ERK2/1 (U0126) and p38MAPK (SB203580). VEGF-induced cell migration was associated with dynamic actin reorganization and focal adhesion as evidenced by increased stress fiber formation and phosphorylation of cofilin-1 and focal adhesion kinase (FAK) and paxillin. Inhibition of JNK1/2, c-Src, and phosphatidylinositol 3-kinase/Akt suppressed VEGF-induced stress fiber formation and cofilin-1 phosphorylation. c-Src inhibition suppressed VEGF-induced phosphorylation of focal adhesion kinase, paxillin, and focal adhesion. VEGF-induced cell migration requires endogenous nitric oxide (NO) as: 1) VEGF-stimulated phosphorylation of endothelial NO synthase (eNOS) via activation of Akt, JNK1/2, and Src; 2) a NO donor diethylenetriamine-NO-stimulated cell migration; and 3) NO synthase inhibition blocked VEGF-induced cell migration. Targeted down-regulation and overexpression of caveolin-1 both inhibited VEGF-induced cell migration. Caveolin-1 down-regulation suppressed VEGF-stimulated phosphorylation of Akt, JNK, eNOS, c-Src, and FAK; however, basal activities of c-Src and FAK were elevated in parallel with increased stress fiber formation and focal adhesion. Caveolin-1 overexpression also inhibited VEGF-induced phosphorylation of Akt, JNK, c-Src, FAK, and eNOS. Thus, VEGF-induced placental endothelial cell migration requires activation of complex pathways that are paradoxically regulated by caveolin-1.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Androstadienes / pharmacology
  • Animals
  • Anthracenes / pharmacology
  • Arteries / cytology*
  • Butadienes / pharmacology
  • CSK Tyrosine-Protein Kinase
  • Caveolin 1 / genetics
  • Caveolin 1 / metabolism
  • Cell Movement / drug effects*
  • Cells, Cultured
  • Electrophoresis, Polyacrylamide Gel
  • Endothelial Cells / drug effects*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Focal Adhesion Protein-Tyrosine Kinases / metabolism
  • Imidazoles / pharmacology
  • Immunoprecipitation
  • JNK Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Mitogen-Activated Protein Kinase 1 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / antagonists & inhibitors
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Nitriles / pharmacology
  • Nitrogen Oxides / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Placenta / blood supply*
  • Pregnancy
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism
  • Pyridines / pharmacology
  • Pyrimidines / pharmacology
  • Sheep
  • Signal Transduction / drug effects
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Wortmannin
  • src-Family Kinases

Substances

  • AG 1879
  • Androstadienes
  • Anthracenes
  • Butadienes
  • Caveolin 1
  • Enzyme Inhibitors
  • Imidazoles
  • Nitriles
  • Nitrogen Oxides
  • Phosphoinositide-3 Kinase Inhibitors
  • Pyridines
  • Pyrimidines
  • U 0126
  • Vascular Endothelial Growth Factor A
  • pyrazolanthrone
  • Nitric Oxide Synthase Type III
  • Protein-Tyrosine Kinases
  • CSK Tyrosine-Protein Kinase
  • Focal Adhesion Protein-Tyrosine Kinases
  • src-Family Kinases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • SB 203580
  • Wortmannin